Literature DB >> 17441292

Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas.

Antonia E Stephen1, Sanford I Roth, David W Fardo, Dianne M Finkelstein, Gregory W Randolph, Randall D Gaz, Richard A Hodin.   

Abstract

OBJECTIVE: To investigate why some patients with single parathyroid adenomas have negative preoperative sestamibi scans.
DESIGN: Retrospective review.
SETTING: Tertiary care center. PATIENTS: Twenty-one patients with false-negative (FN) scans were compared with 22 patients with true-positive (TP) scans. All patients had single parathyroid adenomas.
INTERVENTIONS: Neck exploration and removal of parathyroid adenomas. MAIN OUTCOME MEASURES: Age; sex; preoperative serum calcium and parathyroid hormone levels; gland weight; location; and pathologic features.
RESULTS: There was no significant difference in age or preoperative serum calcium or parathyroid hormone levels. Gland weight was greater in the TP group compared with the FN group (mean +/- SD, 1336 +/- 1603 mg vs 475 +/- 365 mg; P = .04); 13 (62%) of the 21 glands in the FN group were located in the upper position, compared with 6 (27%) of the 22 glands in the TP group (P = .03). Ten of the 22 glands in the TP group consisted predominantly of oxyphil cells, compared with 2 of the 21 glands in the FN group (P = .02). A multivariate logistic regression model yielded the following factors that predicted an accurate scan: higher percentage of oxyphil cells (P = .03), heavier gland (P = .03), female sex (P = .04), and gland location in the lower position (P = .04).
CONCLUSIONS: Smaller-volume parathyroid adenomas and those in the upper position are less likely to be localized with sestamibi scans. A TP scan correlates with oxyphil cell predominance, supporting a role for the mitochondrial-rich cell in sestamibi uptake and retention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17441292     DOI: 10.1001/archsurg.142.4.381

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  13 in total

1.  Validation of the "Perrier" parathyroid adenoma location nomenclature.

Authors:  Haggi Mazeh; Samantha J Stoll; Jessica B Robbins; Rebecca S Sippel; Herbert Chen
Journal:  World J Surg       Date:  2012-03       Impact factor: 3.352

2.  Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism.

Authors:  Linwah Yip; Daniel A Pryma; John H Yim; Sally E Carty; Jennifer B Ogilvie
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

3.  Pre-operative localization of abnormal parathyroid tissue by 99mTc-sestamibi in primary hyperparathyroidism using four-quadrant site analysis: an evaluation of the predictive value of vitamin D deficiency.

Authors:  Yu-Kwang Donovan Tay; Randy Yeh; Jennifer H Kuo; Catherine McManus; James A Lee; John P Bilezikian
Journal:  Endocrine       Date:  2018-02-05       Impact factor: 3.633

Review 4.  Imaging for primary hyperparathyroidism--an evidence-based analysis.

Authors:  Radu Mihai; Dietmar Simon; Per Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

5.  Impact of thyroid nodular disease on 99mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism.

Authors:  Joaquin Gómez-Ramírez; Juan Jose Sancho-Insenser; Jose Antonio Pereira; Jaime Jimeno; Assumpta Munné; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2010-07-14       Impact factor: 3.445

6.  Fluorescence-guided minimally invasive parathyroidectomy: clinical experience with a novel intraoperative detection technique for parathyroid glands.

Authors:  Ruediger L Prosst; Johannes Weiss; Linus Hupp; Frank Willeke; Stefan Post
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

7.  A new classification of positive sestamibi and ultrasound scans in parathyroid localization.

Authors:  Orhan Agcaoglu; Shamil Aliyev; Katy Heiden; Donald Neumann; Mira Milas; Jamie Mitchell; Allan E Siperstein; Eren Berber
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

8.  Sestamibi (99mTc) scan as a single localization modality in primary hyperparathyroidism and factors impacting its accuracy.

Authors:  Yousof Alabdulkarim; Edgard Nassif
Journal:  Indian J Nucl Med       Date:  2010-01

9.  Impact of adenoma weight and ectopic location of parathyroid adenoma on localization study results.

Authors:  Yeşim Erbil; Umut Barbaros; Mustafa Tükenmez; Halim Işsever; Artür Salmaslioğlu; Işik Adalet; Selçuk Ozarmağan; Serdar Tezelman
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

10.  Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism?

Authors:  Linwah Yip; Daniel A Pryma; John H Yim; Mohamed A Virji; Sally E Carty; Jennifer B Ogilvie
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.